219. CDK 4/6 Inhibitors: What To Do When They Stop Working
This episode of Breast Cancer Conversations discusses strategies when CDK4-6 inhibitors cease to be effective. It emphasizes the importance of biopsies to identify mutations like PIK3CA, which guide treatment choices involving drugs such as PIQRAY, Faslodex, Trucap, Orserdo, and…